Reduced platelet cytochrome c oxidase activity in Alzheimer's disease

Neurology. 1994 Jun;44(6):1086-90. doi: 10.1212/wnl.44.6.1086.

Abstract

We evaluated a simplified method for preparation and analysis of platelet cytochrome c oxidase activity in Alzheimer's disease (AD) and control patients. Mean cytochrome c oxidase activity in controls (n = 17) was 0.233 sec-1/mg whereas mean cytochrome c oxidase activity in Alzheimer patients (n = 19) was 0.193 sec-1/mg, p = 0.033. Complex III (ubiquinol:cytochrome c oxidoreductase), complex II (succinic dehydrogenase), and citrate synthase were all assayed as internal controls and were not significantly different in controls and Alzheimer patients. There is a relatively specific loss of platelet cytochrome c oxidase activity in Alzheimer disease patients.

Publication types

  • Research Support, U.S. Gov't, P.H.S.

MeSH terms

  • Aged
  • Alzheimer Disease / enzymology*
  • Blood Platelets / enzymology*
  • Electron Transport Complex IV / blood*
  • Female
  • Humans
  • Male
  • Mitochondria / enzymology

Substances

  • Electron Transport Complex IV